Venus Medtech Trims Loss in 2023 as Revenue Grows Nearly 21%-- Venus Medtech narrowed its loss attributable to owners of the parent to 720.9 million yuan in 2023, from 1.06 billion yuan in the year-ago period, according to a March 28 filing with the Hong...